Troponin University
Myostatin inhibitors (general class) monograph
Justin Harris — IFBB Pro Coach
Written & affirmed by Justin Harris — September 4, 2026 · 3 min read
Coach Voice
Myostatin inhibitors are extremely interesting on paper — myostatin is a brake on muscle growth — but the human data has been underwhelming. You can get lean-mass increases without matching strength or function. Nothing in the class is approved for bodybuilding, WADA bans the pathway, and research-chem versions are likely fake. The potential of inhibiting myostatin is still intriguing, but it hasn’t panned out yet.
Myostatin inhibitors (general class)
Myostatin inhibitors are extremely interesting on paper. Myostatin (GDF-8) is a TGF-β family ligand that puts a brake on skeletal muscle growth. Knock that brake off — antibody, propeptide, follistatin-type binder, ActRIIB decoy, whatever the molecule is — and muscle mass can go up. That part is not fake science.
The human payoff has been underwhelming. Trials in wasting, sarcopenia, dystrophy, cachexia, and COPD-related muscle loss often move lean mass without matching strength or function. Guys hear "block myostatin" and picture a free ticket to size that actually works. What you usually get is more mass on paper that does not turn into the kind of performance or physique change people expect from the hype. The potential is still intriguing. It hasn’t panned out yet.
Subscribers keep reading
The rest of this lecture is part of TroponinIQ
2 more minutes of this lecture — plus the full Troponin University library and the TroponinIQ AI coach built on the same coaching reasoning — unlocks with any subscription.
Already a subscriber? Sign in and this page unlocks.
Justin's methods
Entry-level access to Justin's brain
$29.99/mo
Cancel anytime. Secure checkout powered by Stripe.
Deeper access
Premium access to Justin's brain
$49.99/mo
Cancel anytime. Secure checkout powered by Stripe.
Upgrading? You'll be prorated for the rest of your current cycle.